1. Arai K, Jin G, Navaratna D, Lo EH. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J 2009; 276: 4644-4652.
2.
Boehncke WH. Systemic inflammation and cardiovascular comorbidity in psoriasis patients: Causes and consequences. Front Immunol 2018; 9: 579.
3.
Bozorgi H, Zamani M, Motaghi E, Eslami M. Dexmedetomidine as an analgesic agent with neuroprotective properties: Experimental and clinical aspects. J Pain Palliat Care Pharmacother 2021; 35: 215-225.
4.
Bylund DB, Blaxall HS, Iversen LJ, Caron MG, Lefkowitz RJ, Lomasney JW. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 1992; 42: 1-5.
5.
Cheng J, Zhu P, Qin H, Li X, Yu H, Peng X. Dexmedetomidine attenuates cerebral ischemia/reperfusion injury in neonatal rats by inhibiting TLR4 signaling. J Int Med Res 2018; 46: 2925-2932.
6.
Fagerholm V, Haaparanta M, Scheinin M. a2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 2011; 108: 365-370.
7.
Herz J, Hagen SI, Bergmüller E, Sabellek P, Göthert JR, Buer J, Hansen W, Hermann DM, Doeppner TR. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis 2014; 62: 456-468.
8.
Howell JA, Bidwell GL, 3rd. Targeting the NF-kB pathway for therapy of ischemic stroke. Ther Deliv 2020; 11: 113-123.
9.
Jamison JT, Kayali F, Rudolph J, Marshall M, Kimball SR, DeGracia DJ. Persistent redistribution of poly-adenylated mRNAs correlates with translation arrest and cell death following global brain ischemia and reperfusion. Neuroscience 2008; 154: 504-520.
10.
Jangholi E, Sharifi ZN, Hoseinian M, Zarrindast MR, Rahimi HR, Mowla A, Aryan H, Javidi MA, Parsa Y, Ghaffarpasand F, Yadollah-Damavandi S, Arani HZ, Shahi F, Movassaghi S. Verapamil inhibits mitochondria-induced reactive oxygen species and dependent apoptosis pathways in cerebral transient global ischemia/reperfusion. Oxid Med Cell Longev 2020; 2020: 5872645.
11.
Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010; 87: 779-789.
12.
Krishnamurthi RV, Ikeda T, Feigin VL. Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: A systematic analysis of the Global Burden of Disease Study 2017. Neuroepidemiology 2020; 54: 171-179.
13.
Lankadeva YR, Ma S, Iguchi N, Evans RG, Hood SG, Farmer DGS, Bailey SR, Bellomo R, May CN. Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury. Kidney Int 2019; 96: 1150-1161.
14.
Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, Hopkins LN, Mocco J. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009; 40: 3552-3556.
15.
Li A, Yuen VM, Goulay-Dufay S, Kwok PC. Pharmacokinetics and pharmacodynamics of dexmedetomidine. Drug Dev Ind Pharm 2016; 42: 1917-1927.
16.
Li X, Huang L, Liu G, Fan W, Li B, Liu R, Wang Z, Fan Q, Xiao W, Li Y, Fang W. Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-κB pathway in rats. J Ethnopharmacol 2020; 249: 112365.
17.
Li Y, Guo S, Liu W, Jin T, Li X, He X, Zhang X, Su H, Zhang N, Duan C. Silencing of SNHG12 enhanced the effectiveness of MSCs in alleviating ischemia/reperfusion injuries via the PI3K/AKT/mTOR signaling pathway. Front Neurosci 2019; 13: 645.
18.
Liaquat Z, Xu X, Zilundu PLM, Fu R, Zhou L. The current role of dexmedetomidine as neuroprotective agent: An updated review. Brain Sci 2021; 11: 846.
19.
Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
20.
Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth 2015; 115: 171-182.
21.
Mei B, Li J, Zuo Z. Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central a2A adrenoceptor. Brain Behav Immun 2021; 91: 296-314.
22.
Mu Y, Mei Y, Chen Y, Li Y, Zhu D, Cui J, Yu L. Perisciatic nerve dexmedetomidine alleviates spinal oxidative stress and improves peripheral mitochondrial dynamic equilibrium in a neuropathic pain mouse model in an AMPK-dependent manner. Dis Markers 2022; 2022: 6889676.
23.
Naderi Y, Sabetkasaei M, Parvardeh S, Zanjani TM. Neuroprotective effect of minocycline on cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory and anti-oxidant properties in male rat. Brain Res Bull 2017; 131: 207-213.
24.
Said MF, Islam AA, Massi MN, Prihantono. Effect of erythropoietin administration on the expression of brain-derived neurotrophic factor, stromal cell-derived Factor-1, and neuron-specific enolase in traumatic brain injury: A literature review. Ann Med Surg (Lond) 2021; 69: 102666.
25.
Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2002; 2: 455-463.
26.
Snow SJ. Stroke and t-PA – triggering new paradigms of care. N Engl J Med 2016; 374: 809-811.
27.
Wang J, Xin Y, Chu T, Liu C, Xu A. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-kB signaling pathway. Biomed Pharmacother 2022; 150: 113006.
28.
Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G, Ma D. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth 2019; 123: 777-794.
29.
Wang W, Li M, Chen Q, Wang J. Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: Mechanisms, models, and biomarkers. Mol Neurobiol 2015; 52: 1572-1579.
30.
Wang Y, Han R, Zuo Z. Dexmedetomidine-induced neuroprotection: is it translational? Transl Perioper Pain Med 2016; 1: 15-19.
31.
Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 2012; 379: 2364-2372.
32.
Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, Pu C, Jia J, Zhang T, Liu X, Zhang S, Xie P, Fan D, Ji X, Wong KSL, Wang L; China Stroke Study Collaboration. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019; 18: 394-405.
33.
Wu YT, Xie LP, Hua Y, Xu HL, Chen GH, Han X, Tan ZB, Fan HJ, Chen HM, Li J, Liu B, Zhou YC. Tanshinone I inhibits oxidative stress-induced cardiomyocyte injury by modulating Nrf2 signaling. Front Pharmacol 2021; 12: 644116.
34.
Xie W, Zhou P, Sun Y, Meng X, Dai Z, Sun G, Sun X. Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: A comprehensive overview of experimental studies. Cells 2018; 7: 270.
35.
Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke 2012; 7: 378-385.
36.
Xiong X, Xu L, Wei L, White RE, Ouyang YB, Giffard RG. IL-4 is required for sex differences in vulnerability to focal ischemia in mice. Stroke 2015; 46: 2271-2276.
37.
Xu AD, Wang YJ, Wang DZ. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel. CNS Neurosci Ther 2013; 19: 543-548.
38.
Yang X, Geng K, Zhang J, Zhang Y, Shao J, Xia W. Sirt3 mediates the inhibitory effect of Adjudin on astrocyte activation and glial scar formation following ischemic stroke. Front Pharmacol 2017; 8: 943.
39.
Yingze Y, Zhihong J, Tong J, Yina L, Zhi Z, Xu Z, Xiaoxing X, Lijuan G. NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice. J Neuroinflammation 2022; 19: 184.
40.
Zhang HF, Wang JH, Wang YL, Gao C, Gu YT, Huang J, Zhang Z. Salvianolic acid A protects the kidney against oxidative stress by activating the Akt/GSK-3b/Nrf2 signaling pathway and inhibiting the NF-kB signaling pathway in 5/6 nephrectomized rats. Oxid Med Cell Longev 2019; 2019: 2853534.
41.
Zhou Q, Xie D, Chen T, Gao Y, Lin L, Lin X. The effects of dexmedetomidine on the cognitive function of mild cognitive impairment (MCI) rats. Ann Transl Med 2022; 10: 667.
